Marvel Biosciences Corp. MRVL.V Stock
Marvel Biosciences Corp. Price Chart
Marvel Biosciences Corp. MRVL.V Financial and Trading Overview
| Marvel Biosciences Corp. stock price | 0.15 CAD |
| Previous Close | 0.09 CAD |
| Open | 0.09 CAD |
| Bid | 0.09 CAD x N/A |
| Ask | 0.09 CAD x N/A |
| Day's Range | 0.09 - 0.09 CAD |
| 52 Week Range | 0.08 - 0.17 CAD |
| Volume | 28K CAD |
| Avg. Volume | 19.2K CAD |
| Market Cap | 3.58M CAD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.07 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MRVL.V Valuation Measures
| Enterprise Value | 3.08M CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.122 |
Trading Information
Marvel Biosciences Corp. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -10.0000024% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.17 CAD |
| 52 Week Low | 0.08 CAD |
| 50-Day Moving Average | 0.09 CAD |
| 200-Day Moving Average | 0.11 CAD |
MRVL.V Share Statistics
| Avg. Volume (3 month) | 19.2K CAD |
| Avg. Daily Volume (10-Days) | 20.9K CAD |
| Shares Outstanding | 39.79M |
| Float | 32.66M |
| Short Ratio | 0.45 |
| % Held by Insiders | 32.47% |
| % Held by Institutions | 0% |
| Shares Short | 7K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.020% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | July 31, 2022 |
| Most Recent Quarter (mrq) | January 31, 2023 |
| Next Fiscal Year End | July 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -116.44% |
| Return on Equity (ttm) | -380.30% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -1453408 CAD |
| Net Income Avi to Common (ttm) | -1503357 CAD |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 298.33K CAD |
| Total Cash Per Share (mrq) | 0.007 CAD |
| Total Debt (mrq) | 0 CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.024 |
| Book Value Per Share (mrq) | 0 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1250499 CAD |
| Levered Free Cash Flow (ttm) | -655570 CAD |
Profile of Marvel Biosciences Corp.
| Country | Canada |
| State | AB |
| City | Calgary |
| Address | 505 8th Avenue S.W. |
| ZIP | T2P 1G2 |
| Phone | N/A |
| Website | https://marvelbiotechnology.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Marvel Biosciences Corp. operates as a pre-clinical stage pharmaceutical development biotechnology company. It engages in the discovery and development of synthetic derivative compounds of known drugs that inhibit the A2a adenosine receptor. The company offers Nourianz (Istradefylline, KW-6002) and MB-204 an adenosine A2A receptor antagonist. It targets neurological diseases, such as Alzheimer's disease, depression and anxiety, and non-neurological conditions of cancer; and non-alcoholic steatohepatitis. Marvel Biosciences Corp. is headquartered in Calgary, Canada.
Q&A For Marvel Biosciences Corp. Stock
What is a current MRVL.V stock price?
Marvel Biosciences Corp. MRVL.V stock price today per share is 0.15 CAD.
How to purchase Marvel Biosciences Corp. stock?
You can buy MRVL.V shares on the TSXV exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Marvel Biosciences Corp.?
The stock symbol or ticker of Marvel Biosciences Corp. is MRVL.V.
Which industry does the Marvel Biosciences Corp. company belong to?
The Marvel Biosciences Corp. industry is Biotechnology.
How many shares does Marvel Biosciences Corp. have in circulation?
The max supply of Marvel Biosciences Corp. shares is 39.79M.
What is Marvel Biosciences Corp. Price to Earnings Ratio (PE Ratio)?
Marvel Biosciences Corp. PE Ratio is now.
What was Marvel Biosciences Corp. earnings per share over the trailing 12 months (TTM)?
Marvel Biosciences Corp. EPS is -0.07 CAD over the trailing 12 months.
Which sector does the Marvel Biosciences Corp. company belong to?
The Marvel Biosciences Corp. sector is Healthcare.